Clinical Trial Protocol Design Services
Protocol Design for Phase I, Phase II and Phase III Clinical Trials
At TCR-Solutions we provide clinical trial protocol design services that supports early phase studies while enabling scalable delivery across Phase I, Phase II, and Phase III clinical trials.
Our focus is on designing studies that can be successfully delivered by sites, investigators and patients in real-world clinical settings.
We combine scientific rigour with operational feasibility, ensuring that protocols are aligned with site capability, patient pathways, and regulatory requirements, helping sponsors move studies from planning into successful delivery. Our clinical trial protocol design services include:
- Synopsis and full protocol development, aligned with ICH E6(R3) and global standards
- Endpoint selection and statistical input, in collaboration with Clinical Trial Biometrics Services
- Sample size calculation and study design optimisation
- Schedule of assessments and visit flow design, balancing scientific needs with patient accessibility
- Development of Investigator Brochures and Informed Consent Forms
- Protocol amendments, ensuring adaptability as studies progress
We work closely with Clinical Trial Site Selection & Setup Services to ensure feasibility, and with Medical Monitoring Services to ensure clinical relevance and patient safety.
Why Protocol Design Matters In Clinical Trials
Protocol design has a direct impact on how efficiently a clinical trial can progress through regulatory review, site activation, patient recruitment and study delivery.
A protocol that is scientifically strong but operationally impractical can lead to:
- Regulatory queries and approval delays
- Recruitment delays
- High patient burden and drop-out rates
- Increased protocol amendments
This risk is particularly acute in early phase studies, where decisions are time-sensitive, and in Phase III trials, where small inefficiencies are amplified at scale.
At TCR-Solutions, we design clinical trial protocols with delivery in mind from the outset. Our protocols are:
• Feasible at site level
• Patient-centric
• Aligned with regulatory expectations
• Built for execution across Phase I, Phase II and Phase III clinical trials
This approach supports:
- Faster regulatory approvals
- Improved recruitment and retention
- Reduced need for amendments
- Strong alignment between scientific objectives and operational delivery
Frequently Asked Questions
Do you design Phase III protocols?
Yes — while we have strong experience in early phase studies, we support clinical trial protocol design across Phase I, Phase II, and Phase III clinical trials.
Can you optimise an existing protocol?
Yes — we frequently refine sponsor protocols to improve feasibility and execution.